A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial

Published:2014-08-27 Issue:11 Volume:89 Page:1024-1029
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Olivier Gaelle¹,Clavert Aline²,Lacotte-Thierry Laurence¹,Gardembas Martine²,Escoffre-Barbe Martine³,Brion Annie⁴,Cumin Isabelle⁵,Legouffe Eric⁶,Solal-Celigny Philippe⁷,Chabin Michèle¹,Ingrand Pierre⁸⁹,Colombat Philippe¹⁰,Delwail Vincent¹⁸⁹

Affiliation:

1. Department of Oncology-Hematology and Cell Therapy; University Hospital; Poitiers France

2. Department of Hematology; University Hospital; Angers France

3. Department of Hematology; University Hospital; Rennes France

4. Department of Hematology; University Hospital; Besançon France

5. Department of Oncology; General Hospital; Lorient France

6. Clinique de Valdegour; Nîmes France

7. Institut de Cancérologie de l'Ouest; Nantes France

8. INSERM, CIC 1402; Poitiers France

9. Clinical investigation center; University of Poitiers; Poitiers France

10. Department of hematology; University Hospital; Tours France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23812/fullpdf

Reference33 articles.

1. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma;Villano;Br J Cancer,2011

2. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma;O'Neill;Am J Hematol,2013

3. Management of elderly patients with primary central nervous system lymphoma;Darras;Curr Neurol Neurosci Rep,2013

4. How I treat CNS lymphoma;Rubenstein;Blood,2013

5. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center experience;Ney;Cancer,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphoma of the central nervous system originating from the septum pellucidum region: Two case reports with literature review;Medicine;2023-11-17

2. Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-10

3. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial;BMC Cancer;2023-08-18

4. Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first- line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial;2023-07-18

5. A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma;Cancers;2023-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3